ReviewSeminars in immunopathology2019
Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond.
Alexander J Muller et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
161 papers cite itlatest 60 shown
this paperpooled ittrialcites it